These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1290289)

  • 1. [Evaluation of anti-arrhythmia agents in the animal model].
    Lehmann HD
    Z Kardiol; 1992; 81 Suppl 4():127-32. PubMed ID: 1290289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: a rationale for the short-term use of class I drugs against triggered arrhythmias.
    Takahara A; Sugiyama A; Hashimoto K
    Heart Vessels; 2004 Jan; 19(1):43-8. PubMed ID: 14685755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-arrhythmic drugs and heart conduction].
    Furlanello F
    G Clin Med; 1973 Jul; 54(7):382-406. PubMed ID: 4779853
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of class I anti-arrhythmic drugs in infarcted tissue.
    Man RY; Bril A
    Clin Invest Med; 1991 Oct; 14(5):466-75. PubMed ID: 1742923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unwanted cardiovascular effects of anti-arrhythmia agents].
    Libersa C; Caron J; Nisse C; Lacroix D; Fautrez V; Rouet R
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():41-7. PubMed ID: 1726996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pertinence of animal and human models in the evaluation of ventricular anti-arrhythmia agents].
    Funck-Brentano C; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():15-20. PubMed ID: 1726994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The canine virtual ventricular wall: a platform for dissecting pharmacological effects on propagation and arrhythmogenesis.
    Benson AP; Aslanidi OV; Zhang H; Holden AV
    Prog Biophys Mol Biol; 2008; 96(1-3):187-208. PubMed ID: 17915298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potassium channels and arrhythmia].
    Funck-Brentano C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply].
    Gendenshteĭn EI; Kostin IaV; Markelova NN; Balashov VP; Oleĭnikov VE; Perevarin AV
    Farmakol Toksikol; 1990; 53(4):28-30. PubMed ID: 2226754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.